BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29956819)

  • 1. Neutrophils as myeloid-derived suppressor cells.
    Aarts CEM; Kuijpers TW
    Eur J Clin Invest; 2018 Nov; 48 Suppl 2():e12989. PubMed ID: 29956819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils as Suppressors of T Cell Proliferation: Does Age Matter?
    Aarts CEM; Hiemstra IH; Tool ATJ; van den Berg TK; Mul E; van Bruggen R; Kuijpers TW
    Front Immunol; 2019; 10():2144. PubMed ID: 31572368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the origin of myeloid-derived suppressor cells.
    Millrud CR; Bergenfelz C; Leandersson K
    Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences.
    Pillay J; Tak T; Kamp VM; Koenderman L
    Cell Mol Life Sci; 2013 Oct; 70(20):3813-27. PubMed ID: 23423530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli.
    Leiber A; Schwarz J; Köstlin N; Spring B; Fehrenbach B; Katava N; Poets CF; Gille C
    Eur J Immunol; 2017 Jun; 47(6):1009-1021. PubMed ID: 28493377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders.
    Vlkova M; Chovancova Z; Nechvatalova J; Connelly AN; Davis MD; Slanina P; Travnickova L; Litzman M; Grymova T; Soucek P; Freiberger T; Litzman J; Hel Z
    J Immunol; 2019 Jan; 202(1):93-104. PubMed ID: 30487174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.
    Aarts CEM; Hiemstra IH; Béguin EP; Hoogendijk AJ; Bouchmal S; van Houdt M; Tool ATJ; Mul E; Jansen MH; Janssen H; van Alphen FPJ; de Boer JP; Zuur CL; Meijer AB; van den Berg TK; Kuijpers TW
    Blood Adv; 2019 Nov; 3(22):3562-3574. PubMed ID: 31738831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.
    Abedi-Valugerdi M; Wolfsberger J; Pillai PR; Zheng W; Sadeghi B; Zhao Y; Hassan M
    Int Immunopharmacol; 2016 Nov; 40():41-49. PubMed ID: 27580414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Ly6G
    Heim CE; West SC; Ali H; Kielian T
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease.
    Netherby CS; Abrams SI
    Cancer Immunol Immunother; 2017 Aug; 66(8):989-996. PubMed ID: 28224211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.
    Yang Q; Li X; Chen H; Cao Y; Xiao Q; He Y; Wei J; Zhou J
    Oncogene; 2017 May; 36(21):2969-2980. PubMed ID: 28092673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
    Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
    Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
    Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process.
    Salminen A; Kaarniranta K; Kauppinen A
    Ageing Res Rev; 2018 Dec; 48():1-10. PubMed ID: 30248408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.
    Uhel F; Azzaoui I; Grégoire M; Pangault C; Dulong J; Tadié JM; Gacouin A; Camus C; Cynober L; Fest T; Le Tulzo Y; Roussel M; Tarte K
    Am J Respir Crit Care Med; 2017 Aug; 196(3):315-327. PubMed ID: 28146645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.